Back to Search
Start Over
Randomized phase II study of zoledronate dosing every four versus eight weeks in patients with bone metastasis from lung cancer (Hanshin Cancer Group0312)
- Source :
- Lung Cancer. :107261
- Publication Year :
- 2023
- Publisher :
- Elsevier BV, 2023.
- Subjects :
- Pulmonary and Respiratory Medicine
Cancer Research
Oncology
Subjects
Details
- ISSN :
- 01695002
- Database :
- OpenAIRE
- Journal :
- Lung Cancer
- Accession number :
- edsair.doi...........240e1c9b81e8c242206bfe40e3c3638b